Joash Lazarus is a Neurology physician affiliated with Morris Brown College. OpenAlex indexes 11 publications with 210 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3200 Downwood Cir NW
Ste 550
Atlanta, GA 303271610
Telephone
404-351-0205Provider last certified this registry record 15 May 2020.
Industry payments
61 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TG Therapeutics, Inc.Program year202533 payments$55,779openpaymentsdata.cms.gov ↗
- MDD US Operations, LLCProgram year202546 payments$33,175openpaymentsdata.cms.gov ↗
- Neurocrine BioSciences, Inc.Program year202521 payments$18,087openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
88.9%Neuromuscular Blocker88.5%Onabotulinumtoxina100%Part B, office-administered≥49 patientsgamma-Aminobutyric Acid-ergic Agonist0.3%Baclofen100%Part D≥35 patients+ 1 more class in this area
Nervous system
10%Aromatic Amino Acid Decarboxylation Inhibitor2.2%Carbidopa-Levodopa77%Carbidopa-Levodopa Er16%Rytary7%Part D<11 patientsCholinesterase Inhibitor0.7%Donepezil Hcl68%Rivastigmine32%Part D<11 patients+ 25 more classes in this area
Cancer & immunology
0.7%Pyrimidine Synthesis Inhibitor0.2%Teriflunomide100%Part D≥13 patientsCD20-directed Cytolytic Antibody0.2%Kesimpta Pen100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Biomechanical adaptation to repeated slips during standing in people with Parkinson’s disease
Journal of Biomechanics
2026 - Treadmill walking alongside controlled speed and cadence improves gait parameters in Parkinson’s disease: a randomized controlled trial
Annals of Physical and Rehabilitation Medicine
2025 - Adaptation to repeated gait-slip perturbations among individuals with multiple sclerosis
Multiple Sclerosis and Related Disorders
2019 - Relative importance of physical and psychological factors to slowness in people with mild to moderate multiple sclerosis
Multiple Sclerosis and Related Disorders
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”